Literature DB >> 2981098

Purification of phosphatidylinositol synthetase from rat brain by CDP-diacylglycerol affinity chromatography and properties of the purified enzyme.

A Ghalayini, J Eichberg.   

Abstract

A purification procedure for rat brain phosphatidylinositol synthetase (PI synthetase; CDP-1,2-diacyl-sn-glycerol:myo-inositol 3-phosphatidyltransferase; EC 2.7.8.11) is described. The enzyme was purified 200-250-fold from the homogenate by solubilization with Triton X-100 from microsomal membranes and affinity chromatography on CDP-diacylglycerol-Sepharose. Elution of enzyme activity required the presence of Triton X-100, CDP-diacylglycerol, and either phosphatidylcholine or asolectin. The product that was obtained in 5-10% yield from whole brain and in 70% yield from the microsomal fraction contained three protein bands as determined by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The final preparation contained levels of CDP-diacylglycerol hydrolase and CDP-diacylglycerol: sn-glycero-3-phosphate 3-phosphatidyltransferase activities that were less than 1% of PI synthetase activity. The purified enzyme displayed a pH optimum of 8.5-9.0, required either Mg2+ or Mn2+ and exhibited a Km of 4.6 mM for myo-inositol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981098     DOI: 10.1111/j.1471-4159.1985.tb07128.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Effects of NMDA on carbachol-stimulated phosphatidylinositol resynthesis in rat brain cortical slices.

Authors:  H M Lee; C L Huang
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  Inositol has behavioral effects with adaptation after chronic administration.

Authors:  H Cohen; M Kotler; Z Kaplan; M A Matar; O Kofman; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes.

Authors:  X Zhu; J Eichberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues.

Authors:  H U Shetty; R J Siarey; Z Galdzicki; J Stoll; S I Rapoport
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

5.  Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol.

Authors:  P P Godfrey
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

6.  Li+ increases accumulation of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate in cholinergically stimulated brain cortex slices in guinea pig, mouse and rat. The increases require inositol supplementation in mouse and rat but not in guinea pig.

Authors:  C H Lee; J F Dixon; M Reichman; C Moummi; G Los; L E Hokin
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

7.  Identification of rat liver phosphatidylinositol synthase as a 21 kDa protein.

Authors:  M E Monaco; M Feldman; D L Kleinberg
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

8.  Radio-label and mass determinations of inositol 1,3,4,5-tetrakisphosphate formation in rat cerebral cortical slices: differential effects of myo-inositol.

Authors:  P Kurian; N Narang; L J Chandler; F T Crews
Journal:  Neurochem Res       Date:  1993-05       Impact factor: 3.996

9.  The uptake of 3H-labelled monodeoxyfluoro-myo-inositols into thymocytes and their incorporation into phospholipid in permeabilized cells.

Authors:  J Offer; J C Metcalfe; G A Smith
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

10.  Phosphatidylinositol synthase and phosphatidylinositol/inositol exchange reactions in turkey erythrocyte membranes.

Authors:  F McPhee; G Lowe; C Vaziri; C P Downes
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.